In this Compliance Week webinar, we'll explore the most compelling findings from the report, based on independent global ...

Explore the key steps listed below that are involved in identifying, evaluating, and mitigating institutional risks. This process ensures continuous proactive management of potential threats to our ...

The U.S. Food and Drug Administration recently issued a draft guidance titled, “Benefit-Risk Assessment for New Drug and Biological Products,” which aims to provide a clearer understanding how a ...

Environmental contamination control is a crucial aspect of sterile pharmaceutical manufacturing, and risk management is needed to guarantee that the necessary control procedures are in place. The risk ...